Malignant ovarian germ cell tumors: clinico-pathological presentation and survival outcomes

References

• Chow SN, Yang JH, Lin YH, Chen YP, Lai JI, Chen RJ, Malignant ovarian germ cell tumors. Int J Gynaecol Obstet. 1996;53:151–8.
   PubMed Web of Science ®Google Scholar
• Sah SP, Uprety D, Rani S. Germ cell tumors of the ovary: a clinicopathologic study of 121 cases from Nepal. J Obstet Gynaecol Res. 2004;30:303–8.
   PubMed Web of Science ®Google Scholar
• De Backer A, Madern GC, Oosterhuis JW, Hakvoort-Cammel FG, Hazebroek FW. Ovarian germ cell tumors in children: a clinical study of 66 patients. Pediatr Blood Cancer. 2006;46:459–64.
   PubMed Web of Science ®Google Scholar
• Brewer M, Gershenson DM, Herzog CE, Mitchell MF, Silva EG, Wharton JT. Outcome and reproductive function after chemotherapy for ovarian dysgerminoma. J Clin Oncol. 1999;17:2670–5.
   PubMed Web of Science ®Google Scholar
• Perrin LC, Low J, Nicklin JL, Ward BG, Crandon AJ. Fertility and ovarian function after conservative surgery for germ cell tumours of the ovary. Aust N Z J Obstet Gynaecol. 1999;39:243–5.
   PubMed Web of Science ®Google Scholar
• Billmire D, Vinocur C, Rescorla F, Cushing B, London W, Schlatter M, Children's Oncology Group (COG). Outcome and staging evaluation in malignant germ cell tumors of the ovary in children and adolescents: an intergroup study. J Pediatr Surg. 2004;39:424–9.
   PubMed Web of Science ®Google Scholar
• El-Lamie IK, Shehata NA, Abou-Loz SK, El-Lamie KI. Conservative surgical management of malignant ovarian germ cell tumors: the experience of the Gynecologic Oncology Unit at Ain Shams University. Eur J Gynaecol Oncol. 2000;21:605–9.
   PubMed Web of Science ®Google Scholar
• Culine S, Lhomme C, Kattan J, Michel G, Duvillard P, Droz JP. Pure malignant immature teratoma of the ovary: the role of chemotherapy and second-look surgery. Int J Gynecol Cancer. 1995;5:432–7.
   PubMed Web of Science ®Google Scholar
• Slayton RE, Park RC, Silverberg SG, Shingleton H, Creasman WT, Blessing JA. Vincristine, dactinomycin, and cyclophosphamide in the treatment of malignant germ cell tumors of the ovary: A Gynecologic Oncology Group Study (a final report). Cancer. 1985;56:243–8.
   PubMed Web of Science ®Google Scholar
• Williams SD, Blessing JA, Moore DH, Homesley HD, Adcock L. Cisplatin, vinblastine, and bleomycin in advanced and recurrent ovarian germ-cell tumors. A trial of the Gynecologic Oncology Group. Ann Intern Med. 1989;111:22–7.
   PubMed Web of Science ®Google Scholar
• Gershenson DM, Morris M, Cangir A, Kavanagh JJ, Stringer CA, Edwards CL, Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin. J Clin Oncol. 1990;8:715–20.
   PubMed Web of Science ®Google Scholar
• Tangjitgamol S, Manusirivithaya S, Leelahakorn S, Thawaramara T, Suekwatana P, Sheanakul C. The growing teratoma syndrome: a case report and a review of the literature. Int J Gynecol Cancer. 2006;16(Suppl 1):384–90.
   PubMedGoogle Scholar
• Patterson DM, Murugaesu N, Holden L, Seckl MJ, Rustin GJ. A review of the close surveillance policy for stage I female germ cell tumors of the ovary and other sites. Int J Gynecol Cancer. 2008;18:43–50.
   PubMed Web of Science ®Google Scholar
• Skof E, Grasic Kuhar C, Cerar O, Zakotnik B. Survival and fertility of patients with malignant ovarian germ cell tumours. Eur J Gynaecol Oncol. 2004;25:702–6.
   PubMed Web of Science ®Google Scholar
• Malone JM, Gershenson DM, Creasy RK, Kavanagh JJ, Silva EG, Stringer CA. Endodermal sinus tumor of the ovary associated with pregnancy. Obstet Gynecol. 1986;68(3 Suppl):86–9.
   PubMed Web of Science ®Google Scholar
• Robova H, Rob L, Hrehorcak M, Zoban P, Prusa R. Endodermal sinus tumor diagnosed in pregnancy: a case report. Int J Gynecol Cancer. 2007;17:914–6.
   PubMed Web of Science ®Google Scholar
• Karimi Zarchi M, Behtash N, Modares Gilani M. Good pregnancy outcome after prenatal exposure to bleomycin, etoposide and cisplatin for ovarian immature teratoma: a case report and literature review. Arch Gynecol Obstet. 2008;277:75–8.
   PubMed Web of Science ®Google Scholar
• Peccatori F, Bonazzi C, Chiari S, Landoni F, Colombo N, Mangioni C. Surgical management of malignant ovarian germ-cell tumors: 10 years experience of 129 patients. Obstet Gynecol. 1995;86:367–72.
   PubMed Web of Science ®Google Scholar
• Boran N, Tulunay G, Caliskan E, Köse MF, Haberal A. Pregnancy outcomes and menstrual function after fertility sparing surgery for pure ovarian dysgerminomas. Arch Gynecol Obstet. 2005;271:104–8.
   PubMedGoogle Scholar
• Gershenson DM. Management of ovarian germ cell tumors. J Clin Oncol. 2007;25:2938–43.
   PubMed Web of Science ®Google Scholar
• Beiner ME, Gotlieb WH, Korach Y, Shrim A, Stockheim D, Segal Y, Cystectomy for immature teratoma of the ovary. Gynecol Oncol. 2004;93:381–4.
   PubMed Web of Science ®Google Scholar
• Bafna UD, Umadevi K, Kumaran C, Nagarathna DS, Shashikala P, Tanseem R. Germ cell tumors of the ovary: is there a role for aggressive cytoreductive surgery for nondysgerminomatous tumors? Int J Gynecol Cancer. 2001;11:300–4.
   PubMed Web of Science ®Google Scholar
• Ayhan A, Bildirici I, Günalp S, Yuce K. Pure dysgerminoma of the ovary: a review of 45 well staged cases. Eur J Gynaecol Oncol. 2000;21:98–101.
   PubMed Web of Science ®Google Scholar
• Messing MJ, Gershenson DM, Morris M, Burke TW, Kavanagh JJ, Wharton JT. Primary treatment failure in patients with malignant ovarian germ cell neoplasms. Int J Gynecol Cancer. 1992;2:295–300.
   PubMed Web of Science ®Google Scholar
• Mitchell PL, Al-Nasiri N, A'Hern R, Fisher C, Horwich A, Pinkerton CR, Treatment of nondysgerminomatous ovarian germ cell tumors: an analysis of 69 cases. Cancer. 1999;85:2232–44.
   PubMed Web of Science ®Google Scholar
• Li J, Yang W, Wu X. Prognostic factors and role of salvage surgery in chemorefractory ovarian germ cell malignancies: a study in Chinese patients. Gynecol Oncol. 2007;105:769–75.
   PubMed Web of Science ®Google Scholar
• Wu X, Han LY, Xu X, Li Z. Recurrent immature teratoma of the ovary: a case report of radical secondary cytoreduction with replacement of the aortic bifurcation. Gynecol Oncol. 2004;95:746–9.
   PubMed Web of Science ®Google Scholar
• Lai CH, Chang TC, Hsueh S, Wu TI, Chao A, Chou HH, Outcome and prognostic factors in ovarian germ cell malignancies. Gynecol Oncol. 2005;96:784–91.
   PubMed Web of Science ®Google Scholar
• Kumar S, Shah JP, Bryant CS, Imudia AN, Cote ML, Ali-Fehmi R, The prevalence and prognostic impact of lymph node metastasis in malignant germ cell tumors of the ovary. Gynecol Oncol. 2008;110:125–32.
   PubMed Web of Science ®Google Scholar
• Motzer RJ, Nichols CJ, Margolin KA, Bacik J, Richardson PG, Vogelzang NJ, Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors. J Clin Oncol. 2007;25:247–56.
   PubMed Web of Science ®Google Scholar